Health
Novel microfluidic approach to fight cancer could greatly benefit patients – News-Medical.Net
CAR-T biotherapeutics company Carina Biotech and researchers at the University of South Australia have developed a novel approach based on microfluidic technolo…
Reviewed by Emily Henderson, B.Sc.Oct 20 2020
CAR-T biotherapeutics company Carina Biotech and researchers at the University of South Australia have developed a novel approach based on microfluidic technology to “purify” the immune cells of patients in the fight against cancer.
UniSA’s Future Industries Institute PhD student Mona Elsemary has developed a microfluidic approach to purify chimeric antigen receptor (CAR-T) cells, the bioengineered immune cells that are the basis of groundbreaking …
-
General22 hours agoYoung boy flown to Brisbane hospital after K’gari dingo attack
-
General8 hours agoByford rail extension opening marks final stage of Perth Metronet
-
General20 hours agoBritish and US planes fly 12-hour mission to patrol Russian border
-
Noosa News23 hours agoWarm weather could make way for rain with ‘damaging winds, large hail’